PMID- 36633517
OWN - NLM
STAT- MEDLINE
DCOM- 20230217
LR  - 20230217
IS  - 1699-5198 (Electronic)
IS  - 0212-1611 (Linking)
VI  - 40
IP  - 1
DP  - 2023 Feb 15
TI  - [Decreased muscle mass in type-2 diabetes. A hidden comorbidity to consider].
PG  - 59-66
LID - 10.20960/nh.04468 [doi]
AB  - Objectives: an expert report is presented on the situation of loss of muscle mass 
      in people with type 2 diabetes mellitus (T2DM), with a proposal of what the 
      clinical approach to this comorbidity should be, based on the evidence from the 
      literature and clinical experience. Method: a qualitative expert opinion study 
      was carried out using the nominal approach. A literature search on diabetes and 
      muscle was made and submitted to a multidisciplinary group of 7 experts who 
      through a face-to-face meeting discussed different aspects of the role of muscle 
      mass in T2DM. Results: muscle mass must be taken into account in the clinical 
      context of patients with T2DM. It has an enormous impact on patient function and 
      quality of life, and is as important as adequate metabolic control of T2DM. 
      Conclusions: in addition to drug therapy and diet adjustments, aerobic and 
      strength activities are essential for maintaining muscle mass and function in 
      diabetic patients. In concrete situations, artificial oral supplementation 
      specific for muscle care could improve the situation of malnutrition and low 
      muscle mass. Measures such as the walking speed test, chair test, or the SARC-F 
      questionnaire, together with the Barthel index, constitute a first step to 
      diagnose relevant impairment requiring intervention in patients with T2DM. This 
      document seeks to answer some questions about the importance, assessment, and 
      control of muscle mass in T2DM.
FAU - de Luis Roman, Daniel
AU  - de Luis Roman D
AD  - Centro de Investigacion de Endocrinologia y Nutricion Clinica de Valladolid 
      (IENVA). Facultad de Medicina. Universidad de Valladolid.
FAU - Garrachon Vallo, Fernando
AU  - Garrachon Vallo F
AD  - Servicio de Medicina Interna. Hospital Universitario Virgen de Macarena. Sevilla.
FAU - Carretero Gomez, Juana
AU  - Carretero Gomez J
AD  - Servicio de Medicina Interna. Hospital Universitario de Badajoz. Badajoz.
FAU - Lopez Gomez, Juan Jose
AU  - Lopez Gomez JJ
AD  - Centro de Investigacion de Endocrinologia y Nutricion Clinica de Valladolid 
      (IENVA). Hospital Clinico Universitario de Valladolid.
FAU - Tarazona Santabalbina, Francisco Jose
AU  - Tarazona Santabalbina FJ
AD  - Servicio de Geriatria. Hospital Universitario de la Ribera.
FAU - Guzman Rolo, German
AU  - Guzman Rolo G
AD  - Departamento Medico. Laboratorios Abbot.
FAU - Garcia Almeida, Jose M
AU  - Garcia Almeida JM
AD  - UGC de Endocrinologia y Nutricion. Hospital Clinico Virgen de la Victoria.
FAU - Sanz Paris, Alejandro
AU  - Sanz Paris A
AD  - Departmento de Endocrinologia y Nutricion. Hospital Universitario Miguel Servet.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - La masa muscular disminuida en la diabetes de tipo 2. Una comorbilidad oculta que 
      debemos tener en cuenta.
PL  - Spain
TA  - Nutr Hosp
JT  - Nutricion hospitalaria
JID - 9100365
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/complications/epidemiology/drug therapy
MH  - *Sarcopenia/epidemiology
MH  - Quality of Life
MH  - Comorbidity
MH  - Muscles
MH  - Muscle Strength/physiology
OTO - NOTNLM
OT  - Masa muscular. Diabetes de tipo 2. Desnutricion. Sarcopenia. HMB.
EDAT- 2023/01/13 06:00
MHDA- 2023/02/18 06:00
CRDT- 2023/01/12 10:06
PHST- 2023/01/13 06:00 [pubmed]
PHST- 2023/02/18 06:00 [medline]
PHST- 2023/01/12 10:06 [entrez]
AID - 10.20960/nh.04468 [doi]
PST - ppublish
SO  - Nutr Hosp. 2023 Feb 15;40(1):59-66. doi: 10.20960/nh.04468.